Clinical Gastroenterology and Hepatology

Article	Citations
Reply	431
Look for a Physical Health Status Surrogate in Hepatocellular Carcinoma: Have we Found the Holy Grail?	326
Simplifying ADR Reporting: A Worthy Goal, but the Devil is in the Details	254
An Unexpected Subepithelial Lesion: Catching the Diagnosis Earlier!	233
Reply	223
Gastric Emphysema With Hepatic Portal Venous Gas Secondary to Acute Gastric Mucosal Lesion	212
Editorial Board	171
Attribution of Colonoscopy Risk Does Not FIT!	170
Table of Contents	164
Exam 1: Treat to Target: The Role of Histologic Healing in Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis	164
Effects of Tenofovir vs Entecavir on Risk of Hepatocellular Carcinoma in Patients With CHB: A Comment for Moving Forward	155
Issue Highlights	152
Elsewhere in the AGA Journals	151
Correction	146
FODMAPs in IBS: Revisiting Restriction	145
Fecal Microbiota Transplantation (FMT) in Ulcerative Colitis: Holding Out for a Superdonor?	141
Blue Notes	141
Familial Risk of Inflammatory Bowel Disease: A Population-Based Cohort Study in South Korea	137
Ambulatory Acute Kidney Injury in Patients With Cirrhosis Is Common and Burdensome	130
Aseptic Abscess Syndrome With Ulcerative Colitis and Pyoderma Gangrenosum	120
Development of an MRI-Based Prediction Model for Anti-TNF Treatment Failure in Perianal Crohn’s Disease: A Multicenter Study	118
Sugar-Sweetened Beverage, Diet Soda, and Nonalcoholic Fatty Liver Disease Over 6 Years: The Framingham Heart Study	117
Front Cover	116
Editorial Board	112
AGA Clinical Practice Update on Management of Inflammatory Bowel Disease in Patients With Malignancy: Commentary	112

Daily or Twice Daily Treatment With Topical Steroids Results in Similar Responses in Eosinophilic Esophagitis	111
PErsistence and Safety of Subcutaneous Infliximab 1 Year After Switch From Intravenous Route in IBD Patients in REMission	110
Fibrosis-4 Index Predicts Long-Term All-Cause, Cardiovascular and Liver-Related Mortality in the Adult Korean Population	108
Hepatic Artery Pseudoaneurysm After Whipple Procedure	105
Predictors of Placebo Induction Response and Remission in Ulcerative Colitis	105
Extended Risankizumab Treatment in Patients With Crohn’s Disease Who Did Not Achieve Clinical Response to Induction Treatment	103
Modified-Release Phosphatidylcholine (LT-02) for Ulcerative Colitis: Two Double-Blind, Randomized, Placebo-Controlled Trials	101
Development of a Simple, Point-of-Care Device to Test Anorectal Function in Patients with Constipation: Randomized Clinical Trial	100
Nonalcoholic Fatty Liver Disease Natural History: Role of Mathematical Modeling	99
Drug-Related Pneumonitis in Patients Receiving Vedolizumab Therapy for Inflammatory Bowel Disease	99
Low Daily Step Count Is Associated With a High Risk of Hospital Admission and Death in Community-Dwelling Patients With Cirrhosis	97
High Hospitalization Rates and Risk Factors Among Frail Patients With Cirrhosis: A 10-year Population-based Cohort Study	94
In the Era of Direct-Acting Antivirals, Liver Transplant Delisting Due to Clinical Improvement for Hepatitis C Remains Infrequent	94
Fecal Immunochemical Tests: The Right Colorectal Cancer Screening Test for the Average-Risk Population?	93
Gut Microbiome Modulation by Antibiotics in Adult Asthma: A Human Proof-of-Concept Intervention Trial	93
An International Multicenter Comparison of IBD-Related Disability and Validation of the IBDDI	91
HBV RNA, Hepatitis B Core-Related Antigen, and Quantitative Hepatitis B Surface Antigen Biomarkers to Predict Outcome of Antiviral Therapy	91
A Case of Pedunculated Esophageal Neuroendocrine Tumor G1	91
Reply	90
Frequent Abnormal Pancreas Imaging in Patients With Pathogenic ATM, BRCA1, BRCA2, and PALB2 Breast Cancer Susceptibility Variants	89
Assessment and Significance of Histologic Activity in Crohn’s Disease	89
Relative Cost-effectiveness of Management Strategies for Uninvestigated Dyspepsia	88
The Evolving Landscape of Colorectal Cancer Screening and Colonoscopy Practice: Insights From the Japan Polyp Study	86
Ileal Pouch Anal Anastomosis for the Management of Ulcerative Colitis Is Associated With Significant Disability	85
Natural History of Patients Lost to Follow-up After Esophageal Food Impaction	85
Disaggregating Racial and Ethnic Data: A Step Toward Diversity, Equity, and Inclusion	84
Health Disparities in Inflammatory Bowel Disease Care Driven by Rural Versus Urban Residence: Challenges and Potential Solutions	84
Overall and Annual Postcolonoscopy Colorectal Cancer Rates in a Large Integrated Healthcare Setting: A Cross-Sectional Study	84
Association of Statin Usage and the Development of Diabetes Mellitus after Acute Pancreatitis	83
Barrett’s Esophagus Risk Factors in Patients Without Gastroesophageal Reflux: A Large Population-Based Study	83
Australasian Insights and Perspectives on the Burden of Chronic Liver Disease	83
A Novel, Noninvasive Method to Diagnose Active Eosinophilic Esophagitis, Combining Clinical Data and Oral Cavity RNA Levels	83
Editorial Board	82
Endoscopic Polypectomy: How Should We Determine Complete Resection Status?	82
Metabolic Signatures of Healthy Lifestyle Patterns and Colorectal Cancer Risk in a European Cohort	79
Endoscopic Sleeve Gastroplasty Plus Lifestyle Intervention in Patients With Metabolic Dysfunction-associated Steatohepatitis: A Multicenter, Sham-controlled, Randomized Trial	78
Long-term Effectiveness and Safety of Risankizumab in Patients with Crohn’s Disease	78
Genetic Diagnosis Guides Treatment of Autoimmune Enteropathy	76
Sex-Related Differences in the Phenotype and Course of Inflammatory Bowel Disease: SEXEII Study of ENEIDA	74
Perianal Disease in Pediatric-Onset Crohn’s Disease: Incidence, Disease Course, and Long-Term Outcomes	74
AGA Clinical Practice Update on New Technology and Innovation for Surveillance and Screening in Barrett’s Esophagus: Expert Review	72
Update in the Treatment of the Complications of Cirrhosis	72
Effects of Rome IV Definitions of Functional Dyspepsia Subgroups in Secondary Care	71
Benefits and Harms of Hepatocellular Carcinoma Surveillance in a Prospective Cohort of Patients With Cirrhosis	70
Low Incidence of Pulmonary Aspiration During Upper Endoscopy in Patients Prescribed a Glucagon-Like Peptide 1 Receptor Agonist	69
Trends in Etiology-based Mortality From Chronic Liver Disease Before and During COVID-19 Pandemic in the United States	68
AGA Clinical Practice Update on Endoscopic Management of Perforations in Gastrointestinal Tract: Expert Review	68
Functional Gastrointestinal Disorders and Associated Health Impairment in Individuals with Celiac Disease	68
Prevalence of Gastric Precursor Lesions in Countries With Differential Gastric Cancer Burden: A Systematic Review and Meta-analysis	67
An Approach to the Primary and Secondary Prevention of Gastric Cancer in the United States	66

Assessing early post-TIPS hepatic encephalopathy and survival: What key factors remain unaddressed?	66
The Impact of the Social Determinants of Health on Disparities in Inflammatory Bowel Disease	66
Relationship Between Gastric Emptying Rate and Simultaneously Assessed Symptoms in Functional Dyspepsia	65
Comparative Efficacy of Biologics and Small Molecule in Ulcerative Colitis: A Systematic Review and Network Meta-analysis	65
Prevalence and Factors Associated With Statin Use Among Patients With Nonalcoholic Fatty Liver Disease in the TARGET-NASH Study	64
Effectiveness of Reinduction and/or Dose Escalation of Ustekinumab in Crohn’s Disease: A Systematic Review and Meta-analysis	64
The Diagnostic Performance of Fecal Immunochemical Tests for Detecting Advanced Neoplasia at Surveillance Colonoscopy	64
National Trends and Waitlist Outcomes of Locoregional Therapy Among Liver Transplant Candidates With Hepatocellular Carcinoma in the United States	64
Reply	63
Blue Notes	63
Information for Authors and Readers	63
Editorial Board	63
Characterization of Prevalent, Post-Endoscopy, and Incident Esophageal Cancer in the United States: A Large Retrospective Cohort Study	63
Cover	62
Direct Oral Anticoagulants in Budd-Chiari Syndrome: Need a Closer Look!	62
Reply	62
Reply	62
Information for Authors and Readers	62
Editorial Board	61
Table of Contents	61
Reply	61
Information for Authors and Readers	61
Transient Uterine Prolapse: A Rare Complication of Endoscopic Polypectomy	60
Von Willebrand Factor Level Indicate Response to β-Blockers in Cirrhosis: Need a Closer Look!	60
Health Policy Priorities for the Biden Administration	59
Reply	59
Editorial Board	59
Table of Contents	59
Editorial Board	59
Cover	59
Multiple Negative Fecal Immunochemical Tests: Is Testing Really Better?	58
Unusual Presentation of a Crohn’s Disease Patient: Not Your Typical Flare	58
Environmental Toxins in Breast Milk and Risk of Early Onset Colorectal Cancer	57
Reply	57
Hurdles in ERCP Trials: Do We Need to Change the Diagnostic Criteria for Post-ERCP Pancreatitis?	57
Bowel Perforation by Intrauterine Device	57
Needle Track Seeding After Trans-gastric EUS-guided Tissue Sampling: Maybe Not as Rare as You Think	57
Close Observation of the Lateral Walls of the Oropharynx During Esophagogastroduodenoscopy	56
Reply	56
Reply	56
Statins for Chronic Liver Disease and the Need for Randomized Controlled Trials	55
Preoperative Hepatology and Primary Care Visits Improve Postoperative Outcomes in Patients With Cirrhosis Undergoing Surgery	54
A Framework for Creating a FOAMed Organization in Gastroenterology: Lessons Learned from the Liver Fellow Network	54
Foaming at the Varix: Sclerotherapy of Esophageal Varices via Intrahepatic Portal Vein Access	54
Gastroparesis and Chronic Pancreatitis: Are They Truly Related?	53
Long-Term Proton Pump Inhibitor Use: Review of Indications and Special Considerations	53
Assessing Diagnostic Performance of Modifications to the Rome IV Criteria for Irritable Bowel Syndrome	53
Population-based Screening for Hereditary Colorectal Cancer Variants in Japan	53
Primary Sclerosing Cholangitis–Associated Pouchitis: A Distinct Clinical Phenotype	52
Clinical Outcomes of Intraductal Papillary Mucinous Neoplasms With Dilatation of the Main Pancreatic Duct	52
Distinct Clinical Physiologic Phenotypes of Patients With Laryngeal Symptoms Referred for Reflux Evaluation	52
Continuous Risk Score Predicts Waitlist and Post-transplant Outcomes in Hepatocellular Carcinoma Despite Exception Changes	52
An Unusual Complication of Endoscopic Ultrasound-guided Transgastric Liver Biopsy	51
Continuing the Commitment to Diversity, Equity, and Inclusion Within AGA Journals	51
Two vs One Forward View Examination of Right Colon on Adenoma Detection: An International Multicenter Randomized Trial	51
Correction	51
Diverticulosis Is Associated With Internal Hemorrhoids on Colonoscopy: Possible Clues to Etiology	50
Exploring the Early Phase of Crohn’s Disease	50
Value of Ammonia Testing in Clinical Practice	50
Front Cover	50
Reply	50
The New Kids on the Block: Emerging Complementary Colonoscopy Quality Metrics	50
North American Expert Consensus on the Post-procedural Care of Patients After Per-oral Endoscopic Myotomy Using a Delphi Process	49
Risk of Cancer in Biopsy-Proven Alcohol-Related Liver Disease: A Population-Based Cohort Study of 3410 Persons	49
Adenoma Detection Rate (ADR) Irrespective of Indication Is Comparable to Screening ADR: Implications for Quality Monitoring	49
Distinctive Clinical Correlates of Small Intestinal Bacterial Overgrowth with Methanogens	49
Personalized (N-of-1) Clinical Trials for Inflammatory Bowel Disease: Opportunities and Challenges	48
The Role of Resilience in Irritable Bowel Syndrome, Other Chronic Gastrointestinal Conditions, and the General Population	48
Acute-onset Type 1 Diabetes Mellitus and Pancreatic Atrophy Caused by an Immune Checkpoint Inhibitor	47
Bouveret Syndrome Treated With Endoscopic Lithotripsy and Gallbladder Access via Cholecysto-duodenal Fistula	47
Harm-to-Benefit Ratio of Fecal Immunochemical Test–Based Screening for Colorectal Cancer Given Prior Fecal Hemoglobin Concentrations	47
Weight Change and the Development of Nonalcoholic Fatty Liver Disease in Metabolically Healthy Overweight Individuals	47
All-cause and Cause-specific Mortality in Achalasia: A Nationwide Matched Cohort Study	47
Low Colorectal Cancer Risk After Resection of High-Risk Pedunculated Polyps	47
Prolonged Gastrointestinal Manifestations After Recovery From COVID-19	46
Real-world Comparison of SAFE and FIB-4 Scores for Assessing MASLD-Related Fibrosis in a highly diverse urban MASLD population	46
Response to “Recent Advancements and Future Perspectives of Per Oral Endoscopic Myotomy”	46
Significance of Crypt Atypia in Barrett’s Esophagus: A Clinical, Molecular, and Outcome Study	46
A Randomized, Controlled Trial of Efficacy and Safety of Cannabidiol in Idiopathic and Diabetic Gastroparesis	45
Extraintestinal symptoms in irritable bowel syndrome are associated with stress reactivity and the gut microbiome in a sex-dependent manner	45

Uptake of Colorectal Cancer Screening in 45 to 49 Year Olds: An Early-Inning View from the Endoscopy Suite	45
Perianal Fistulizing Crohn’s Disease–Associated Anorectal and Fistula Cancers: Systematic Review and Expert Consensus	45
Nonrecurrence Rate of Underwater EMR for ≤20-mm Nonampullary Duodenal Adenomas: A Multicenter Prospective Study (D-UEMR Study)	45
Safety and Efficacy of Novel Incretin Co-agonist Cotadutide in Biopsy-proven Noncirrhotic MASH With Fibrosis	45
Constrictive and Hypertrophic Strictures in Ileal Crohn’s Disease	45
Birth Cohort Colorectal Cancer (CRC): Implications for Research and Practice	45
The EXTENT Study: Results from an International Expert Delphi Consensus to define Ultrasonographic Parameters for Measuring Bowel Damage in Crohn’s Disease	45
Development of a Practical Guide to Implement and Monitor Diet Therapy for Eosinophilic Esophagitis	45
Comparative Risk of Serious Infections With Biologic Agents and Oral Small Molecules in Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis	45
Real-World Surgical and Endoscopic Recurrence Based on Risk Profiles and Prophylaxis Utilization in Postoperative Crohn’s Disease	45
Diet and Microbiome-Directed Therapy 2.0 for IBD	45
Deficits in Geriatric Assessment Associate With Disease Activity and Burden in Older Patients With Inflammatory Bowel Disease	44
Biologics for Inflammatory Bowel Disease and Their Safety in Pregnancy: A Systematic Review and Meta-analysis	44
Colon Volume by Computed Tomography and Scintigraphic Colonic Transit in Constipated Patients With or Without Redundant Colon	44
Antibody Response Six Months after SARS-CoV-2 mRNA Vaccination in Patients with Inflammatory Bowel Disease	44
Anti-TL1A Antibody PF-06480605 Safety and Efficacy for Ulcerative Colitis: A Phase 2a Single-Arm Study	44
Prior Authorizations Delay Therapy, Impact Decision-making, and Lead to Adverse Events in Inflammatory Bowel Disease: 2022 Provider Survey	44
The Affordable Care Act Improves Access, Survival, and Racial Disparities of Patients with Liver Disease: A Systematic Review	43
Metabolic Dysfunction-Associated Steatotic Liver Disease Facilitates Hepatitis B Surface Antigen Seroclearance and Seroconversion	43
Estimating Global Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease in Overweight or Obese Adults	43
Longitudinal Fecal Calprotectin Profiles Characterize Disease Course Heterogeneity in Crohn’s Disease	43
Upadacitinib in Mothers With Inflammatory Bowel Disease: Placental Transfer and Breast Milk Excretion	43
Drug-induced Liver Injury in Latin America: 10-year Experience of the Latin American DILI (LATINDILI) Network	43
Genetics of Metabolic Dysfunction-associated Steatotic Liver Disease: The State of the Art Update	43
Avoidant Restrictive Food Intake Disorder Prevalent Among Patients With Inflammatory Bowel Disease	43
Development and Validation of a Noninvasive Model for the Detection of High-Risk Varices in Patients With Unresectable Hepatocellular Carcinoma	43
Prediction of Relapse After Anti–Tumor Necrosis Factor Cessation in Crohn’s Disease: Individual Participant Data Meta-analysis of 1317 Patients From 14 Studies	42
Adenoma Detection Rate and Clinical Characteristics Influence Advanced Neoplasia Risk After Colorectal Polypectomy	42
Table of Contents	42
Skills or Pills: Randomized Trial Comparing Hypnotherapy to Medical Treatment in Children With Functional Nausea	42
The Severity of Reduced Esophageal Distensibility Parallels Eosinophilic Esophagitis Disease Duration	42
Elsewhere in the AGA Journals	42
Incidence of and Risk Factors for Colorectal Strictures in Ulcerative Colitis: A Multicenter Study	42
Reply	42
Screening HIV Patients at Risk for NAFLD Using MRI-PDFF and Transient Elastography: A European Multicenter Prospective Study	41
Dietary Fiber is Associated With Decreased Risk of Gastroesophageal Reflux Symptoms	41
Reply	41
Reply	40
Risk Difference of Liver-Related and Cardiovascular Events by Liver Fibrosis Status in Nonalcoholic Fatty Liver Disease	40
Prevalence of Chronic Liver Disease in Cholangiocarcinoma: A Meta-Analysis	40
Bleeding Gastric Teratoma on Adult Patient	40
Reply	40
Characteristics and Risk Factors of Post-Infection Irritable Bowel Syndrome After Campylobacter Enteritis	40
Reply	40
Stratifying Risks of Ileal Pouch Outcomes	40
Reply	39
To Stop or Not to Stop? Predicting Relapse After Anti-TNF Cessation in Patients With Crohn’s Disease	39
Prediction of Postoperative Recurrence in Crohn’s Disease: Where Do We Go From Here?	39
Lymphangioma in a Child Managed With Debulking Surgery	39
Letter Response to: Hernandez-Rocha C et al, Clin Gastroenterol Hepatol 2024	39
Adult-Onset Fontan Circuit Failure: A Rare Cause of Protein-Losing Enteropathy	39
Disparities in Colorectal Cancer Screening Among Asian American Populations and Strategies to Address These Disparities	39
Porcelain Gallbladder	39
Editorial Board	39
Blue Notes	39
Reply	38
Blue Notes	38
Front Cover	38
Ustekinumab and Vedolizumab Safety and Clearance in Pregnancy With Inflammatory Bowel Disease: Stop the Disease, Not the Drug!	38
Editorial Board	38
Information for Authors and Readers	38
Editorial Board	38
Decreasing Case Fatality Rates for Patients With Cirrhosis Infected With SARS-CoV-2: A National COVID Cohort Collaborative Study	37
Reply	37
Repeating Ultrasound for Hepatocellular Carcinoma Detection in Case of Inadequate Liver Visualization: A Matter of Expertise	37
Elsewhere in the AGA Journals	37
Approach to Dietary Restriction in Irritable Bowel Syndrome	37
Nature and Nurture in Familial Aggregation of Steatotic Liver Disease	37
Diffuse Large B-Cell Duodenal Lymphoma Presenting With Obstruction and Pneumatosis	37
Preparing the Next Generation of Gastroenterologists to Tackle Climate Change	37
Hepatitis B RNA and Core-Related Antigen Provide Value Beyond DNA in Evaluating e But Not Surface Antigen Clearance	37
Serum Leucine-Rich α2 Glycoprotein: A Novel Biomarker For Small Bowel Mucosal Activity in Crohn’s Disease	36
Symptom Classes in Decompensated Liver Disease	36
Abdomino-anal Dyscoordination in Defecatory Disorders	36
Real-World Effectiveness of Lenvatinib in Hepatocellular Carcinoma Patients with Nonalcoholic Steatohepatitis	36
Endoscopic Submucosal Dissection for Esophageal Squamous Cell Carcinoma With Varices Using Red Dichromatic Imaging	36
Patterns of Alcohol Use After Early Liver Transplantation for Alcoholic Hepatitis	36
Reply	36
Immunomodulator Withdrawal From Anti-TNF Therapy Is Not Associated With Loss of Response in Inflammatory Bowel Disease	36
Interventional radiological management for Budd-Chiari syndrome: a 10-year retrospective, multicenter survey on 997 patients in China	36
AGA Clinical Practice Update on Endoscopic Lifting Agents: Commentary	35
Reply	35
Strong Response to SARS-CoV-2 Vaccine Additional Doses Among Patients With Inflammatory Bowel Diseases	35
A Randomized Phase II Study of Efmarodocokin Alfa, an interleukin-22 Agonist, Versus Vedolizumab in Patients With Ulcerative Colitis	35
Prevalence of Liver Steatosis and Fibrosis in Adults With Primary Hypobetaliproteinemia: Results From the HYPOCHOL Study	35
Contemporary Changes in Etiology for Hepatocellular Carcinoma in Liver Transplantation	35
Incomplete Response of Gastroesophageal Reflux Symptoms Poorly Predicts Erosive Esophagitis or Barrett’s Esophagus	35
Perceptions, Definitions, and Therapeutic Interventions for Occasional Constipation: A Rome Working Group Consensus Document	35
Psychiatric Comorbidities Are Highly Prevalent in Nonesophageal Eosinophilic Gastrointestinal Diseases	35
Baseline Hepatitis B Virus Surface Antigen Titers in Childhood Predict the Risk of Advanced Liver Fibrosis in Adulthood	35
Front Cover	34
Declines in Colorectal Cancer Incidence and Mortality Rates Slow Among Older Adults	34
Clinical, Pathology, Genetic, and Molecular Features of Colorectal Tumors in Adolescents and Adults 25 Years or Younger	34
Diagnosis of Retrograde Cricopharyngeus Dysfunction Using High Resolution Impedance Manometry and Comparison With Control Subjects	34
Crafting a Therapeutic Pyramid for Eosinophilic Esophagitis in the Age of Biologics	34